Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional PRP vs Metformin vs Cryotherapy for Non-genital Warts
NCT06691542Phase 3Not yet recruiting
- Sponsor
- Assiut University
- Start
- Nov 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules, Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Phase 3, randomised, open-label trial of metformin and platelet-rich plasma in warts (3 arms), sponsored by Assiut University. Primary endpoint: Complete resolution of the wart(s) at 3 months. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
metforminplatelet-rich plasma
03
Conditions
warts
Beyond the preview
Go deeper on NCT06691542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06691542.